Tanabe Research Laboratories USA Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Tanabe Research Laboratories USA Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013266
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tanabe Research Laboratories USA Inc (TRL), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a healthcare research center that discovers biological drugs. The center conducts research on metabolics, inflammation and immunology. Its products are used for the therapy of serious diseases with unmet needs. TRL conducts antibody related research to target specific immune cells and soluble factors, and investigates new methods for modulating immune cell functions. The center also works with various companies and academic research organizations. TRL is headquartered in San Diego, California, the US.

Tanabe Research Laboratories USA Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
X-BODY Enters Into Research Agreement With Tanabe Research Labs 10
Licensing Agreements 11
Tanabe Research Labs Enters into a Licensing Agreement with MedImmune 11
Covagen Expands Licensing Agreement With Mitsubishi Tanabe Pharma And Tanabe Research Labs 12
Covagen Enters Into Licensing Agreement With Mitsubishi Tanabe Pharma And Tanabe Research Labs 14
Tanabe Research Laboratories USA Inc – Key Competitors 16
Tanabe Research Laboratories USA Inc – Key Employees 17
Tanabe Research Laboratories USA Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Key Facts 2
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tanabe Research Laboratories USA Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
X-BODY Enters Into Research Agreement With Tanabe Research Labs 10
Tanabe Research Labs Enters into a Licensing Agreement with MedImmune 11
Covagen Expands Licensing Agreement With Mitsubishi Tanabe Pharma And Tanabe Research Labs 12
Covagen Enters Into Licensing Agreement With Mitsubishi Tanabe Pharma And Tanabe Research Labs 14
Tanabe Research Laboratories USA Inc, Key Competitors 16
Tanabe Research Laboratories USA Inc, Key Employees 17

★海外企業調査レポート[Tanabe Research Laboratories USA Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Manz AG (M5Z):電力:M&Aディール及び事業提携情報
    Summary Manz AG (Manz) is a manufacturer of high-technology equipment. It produces displays, printed circuit boards and other components for electronic devices. The company provides production equipment for lithium-ion battery cells, super capacitors, battery systems, and capacitors. Manz offers ind …
  • China National Nuclear Power Co Ltd (601985):電力:M&Aディール及び事業提携情報
    Summary China National Nuclear Power Co Ltd (CNNPC), a subsidiary of China National Nuclear Corp is a nuclear energy company. The company provides activities such as development, investment, construction, operations and management of nuclear power projects and technical research in the safe operatio …
  • Guala Closures S.p.A.:企業の戦略・SWOT・財務情報
    Guala Closures S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Guala Closures S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • U.P. Hotels Ltd.:企業の戦略・SWOT・財務情報
    U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report Summary U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Diamond Offshore Drilling Inc (DO)-石油・ガス分野:企業M&A・提携分析
    Summary Diamond Offshore Drilling, Inc. (Diamond Offshore) is an offshore oil and gas drilling company, which provides contract drilling services to the energy industry. It operates through a fleet of offshore drilling rigs comprising semisubmersibles, jack-ups, and dynamically positioned drillships …
  • AECI Ltd (AFE):企業の財務・戦略的SWOT分析
    AECI Ltd (AFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Kokuyo Camlin Ltd (KOKUYOCMLN):企業の財務・戦略的SWOT分析
    Kokuyo Camlin Ltd (KOKUYOCMLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Probiogen AG-製薬・医療分野:企業M&A・提携分析
    Summary Probiogen AG (Probiogen), a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeu …
  • Bespak Europe Ltd:企業の製品パイプライン分析2018
    Summary Bespak Europe Ltd (Bespak), a subsidiary of Consort Medical plc is a medical device company that provides inhalation systems. The company provides products such as inhalation devices, injectables, medical check valves and nasal products. Its inhalation devices comprise dose counting actuator …
  • Pyxant Labs Inc-製薬・医療分野:企業M&A・提携分析
    Summary Pyxant Labs Inc (Pyxant) is a bioanalytical laboratory that provides good laboratory practice (GLP) bioanalytical chemistry support and contract research services. The laboratory offers services such as picogram-level bioanalytical method development, analytical and bioanalytical support for …
  • Alcon Laboratories Inc:製品パイプライン分析
    Summary Alcon Laboratories Inc (Alcon), a division of Novartis AG, develops and manufactures devices in the field of Ophthalmology. The company’s portfolio encompasses contact lenses and surgical products. Alcon’s products are used for the treatment of various conditions such as cataracts, glaucoma, …
  • Queen Mary University of London-製薬・医療分野:企業M&A・提携分析
    Summary Queen Mary University of London (Queen Mary), formerly Queen Mary and Westfield College, a subsidiary of University of London, is a research university that offers undergraduate and postgraduate education; and research programs. The university provides graduation and education services in ar …
  • Seiko Optical Products Co Ltd:企業の戦略的SWOT分析
    Seiko Optical Products Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Vietnam Joint Stock Commercial Bank for Industry and Trade:企業の戦略・SWOT・財務情報
    Vietnam Joint Stock Commercial Bank for Industry and Trade - Strategy, SWOT and Corporate Finance Report Summary Vietnam Joint Stock Commercial Bank for Industry and Trade - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the …
  • Bassett Furniture Industries Inc (BSET):企業の財務・戦略的SWOT分析
    Bassett Furniture Industries Inc (BSET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Tepha Inc-医療機器分野:企業M&A・提携分析
    Summary Tepha Inc (Tepha) is a medical device company that develops and commercializes medical device components and finished goods. The company offers products such as absorbable monofilament suture, absorbable monofilament mesh, composite mesh and absorbable surgical film. It also provides platfor …
  • Pfenex Inc (PFNX):企業の財務・戦略的SWOT分析
    Summary Pfenex Inc (Pfenex) is a biologics company that develops biosimilar therapeutics. The company’s lead product candidate includes, PF582, a biosimilar candidate which is used for the treatment of retinal diseases. It also develops PF530, a biosimilar candidate for the treatment of multiple scl …
  • Inter Parfums Inc (IPAR):企業の財務・戦略的SWOT分析
    Summary Inter Parfums Inc (Inter Parfums) is a consumer goods company that manufactures, develops, and markets fragrance and beauty care products. The company’s products include cosmetics, fragrances, personal care products, and fragrance related products. Its personal care products comprise cosmeti …
  • Tianda Pharmaceuticals Ltd (455):企業の財務・戦略的SWOT分析
    Summary Tianda Pharmaceuticals Ltd (Tianda Pharma), a subsidiary of Tianda Group Ltd, is a healthcare supplement product manufacturer that researches, develops, manufactures and markets biotechnology, pharmaceutical and health care products. The company provides products covering various therapeutic …
  • Syndax Pharmaceuticals Inc (SNDX):医療機器:M&Aディール及び事業提携情報
    Summary Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the tre …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆